Webinar

Benefits Of 5KL Bioreactor When Outsourcing Late-Phase Biologics Drug Substance Manufacturing

Source: Thermo Fisher Scientific

When you look at the current challenges in upstream bioprocessing, two come to the forefront as critical. The first is intensified cell culture processes which present a challenge for the bioreactor space—specifically for improving the mixing and mass transfer of performance. The second is a demand for flexible and efficient manufacturing which is driven by a shift in volumetric demand profiles.

Watch this webinar today and discover how Thermo Fisher Scientific is addressing and overcoming these two challenges of bioprocessing.

access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Thermo Fisher Scientific